Detalhe da pesquisa
1.
Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study.
Pharmacoepidemiol Drug Saf
; 25(1): 90-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26468002
2.
Personalizing health care: feasibility and future implications.
BMC Med
; 11: 179, 2013 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23941275
3.
Interpreting the Benefit and Risk Data in Between-Drug Comparisons: Illustration of the Challenges Using the Example of Mefenamic Acid versus Ibuprofen.
Pharmaceutics
; 14(10)2022 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36297674
4.
Why are self-medication opportunities limited in Austria? An interview study and comparison with other countries.
PLoS One
; 16(1): e0245504, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493218
5.
Sex-Related Differences in Drugs with Anti-Inflammatory Properties.
J Clin Med
; 10(7)2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33916167
6.
Mini-review: medication safety of red yeast rice products.
Int J Gen Med
; 12: 167-171, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31118742
7.
[Generic drugs: quality, efficacy, safety and interchangeability]. / Generika: Qualität, Wirksamkeit, Sicherheit und Austauschbarkeit.
Wien Klin Wochenschr
; 120(3-4): 63-9, 2008.
Artigo
em Alemão
| MEDLINE | ID: mdl-18322766
8.
Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study.
Appl Health Econ Health Policy
; 13(2): 193-205, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25536928
9.
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.
Front Pharmacol
; 5: 109, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24959145
10.
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.
Front Pharmacol
; 4: 39, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23717279